BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16360896)

  • 1. Therapeutic options for the treatment of cancer-associated thrombosis.
    Cunningham RS
    Semin Oncol Nurs; 2005 Nov; 21(4 Suppl 1):21-40. PubMed ID: 16360896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nursing interventions in the management of patients with cancer-associated thrombosis.
    Gillespie TW
    Semin Oncol Nurs; 2005 Nov; 21(4 Suppl 1):50-9. PubMed ID: 16360898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of thrombosis in the cancer patient.
    Andrea N; Ansell J
    J Support Oncol; 2003; 1(4):235-8, 240-2; discussion 239-40, 243-5. PubMed ID: 15334865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal clotting in cancer: an overview of pathophysiology and etiology.
    Viale PH
    Semin Oncol Nurs; 2005 Nov; 21(4 Suppl 1):12-20. PubMed ID: 16360895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of low-molecular-weight heparins in the treatment and secondary prevention of cancer-associated thrombosis.
    Grande C; Caparro M
    Semin Oncol Nurs; 2005 Nov; 21(4 Suppl 1):41-9. PubMed ID: 16360897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous thromboembolism in patients with cancer. Part I. Survey of oncology nurses' attitudes and treatment practices for ambulatory settings.
    Viale PH; Schwartz RN
    Clin J Oncol Nurs; 2004 Oct; 8(5):455-61. PubMed ID: 15515279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism in patients with cancer. Part II. Current treatment strategies.
    Viale PH; Schwartz RN
    Clin J Oncol Nurs; 2004 Oct; 8(5):465-9. PubMed ID: 15515280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and management of cancer-associated acute venous thromboembolism: findings from the MASTER Registry.
    Imberti D; Agnelli G; Ageno W; Moia M; Palareti G; Pistelli R; Rossi R; Verso M;
    Haematologica; 2008 Feb; 93(2):273-8. PubMed ID: 18223291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of low-molecular-weight heparins as supportive care therapy in cancer-associated thrombosis.
    Cunningham RS
    Semin Oncol; 2006 Apr; 33(2 Suppl 4):S17-25; quiz S41-2. PubMed ID: 16638457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.
    Nishioka J; Goodin S
    J Oncol Pharm Pract; 2007 Jun; 13(2):85-97. PubMed ID: 17873108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and initial treatment of venous thromboembolism in patients with cancer.
    Streiff MB
    J Clin Oncol; 2009 Oct; 27(29):4889-94. PubMed ID: 19738109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the practical advantages of low molecular weight heparin in the treatment of cancer-related venous thromboembolism.
    Rhodes S; Bond S
    Eur J Oncol Nurs; 2008 Dec; 12(5):425-9. PubMed ID: 18842458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Need for inferior vena cava filters in cancer patients: a surrogate marker for poor outcome.
    Barginear MF; Lesser M; Akerman ML; Strakhan M; Shapira I; Bradley T; Budman DR
    Clin Appl Thromb Hemost; 2009; 15(3):263-9. PubMed ID: 18385149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [2008 Standards, Options: recommendations for venous thromboembolic events (VTE) treatment and central venous catheter thrombosis (CVCT) management in cancer patients].
    Debourdeau P; Farge-Bancel D; Bosquet L; Kassab-Chahmi D; Cajfinger F; Desmurs-Clavel H; Desruennes E; Douard MC; Elias A; Elalamy I; Grange C; Hocini H; Kriegel I; Le Gal G; Lévesque H; Mahé I; Meyer G; Mismetti P; Pavic M; Quéré I; Renaudin JM; Scrobohaci ML
    Bull Cancer; 2008; 95(7):750-61. PubMed ID: 18755652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of cancer-associated thrombosis: distinguishing among antithrombotic agents.
    Pruemer J
    Semin Oncol; 2006 Apr; 33(2 Suppl 4):S26-39; quiz S41-2. PubMed ID: 16638458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical challenges: chemotherapy-induced peripheral neuropathy.
    Paice JA
    Semin Oncol Nurs; 2009 May; 25(2 Suppl 1):S8-19. PubMed ID: 19447319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the genetic determinants of pain and pain management.
    Miaskowski C
    Semin Oncol Nurs; 2009 May; 25(2 Suppl 1):S1-7. PubMed ID: 19447317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of venous thromboembolism in perioperative period].
    Nakamura M
    Masui; 2007 Jul; 56(7):787-93. PubMed ID: 17633838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding cerebral edema: implications for oncology nurses.
    Saba MT; Magolan JM
    Oncol Nurs Forum; 1991 Apr; 18(3):499-505. PubMed ID: 2057394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation in the treatment of established venous thromboembolism in patients with cancer.
    Lee AY
    J Clin Oncol; 2009 Oct; 27(29):4895-901. PubMed ID: 19738121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.